tokens: METHODS We examined genomic DNA from 83 ( for BRCA1 185delAG ) or 82 ( for BRCA2 6174delT ) Ashkenazi Jewish prostate cancer patients , most of whom were treated at a relatively young age , for the most common germline mutation in each gene seen in the Ashkenazi population .